Benefits
Blood pressure reduction
A meta-analysis of 11 randomized trials (860 people) found black seed lowered systolic blood pressure by about 3.3 mmHg and diastolic by about 2.8 mmHg versus control over roughly 8 weeks, more with seed powder than with oil. A 28-day trial of a seed extract in 76 older adults with high blood pressure found no significant difference from placebo.
Blood sugar and HbA1c improvement
A pooled analysis of 7 trials in adults with type 2 diabetes found black seed lowered fasting blood sugar by about 18 mg/dL and HbA1c by about 0.7 percentage points versus control. The analysis included only a few studies and the effects were modest, so it is best seen as a complement to diet, exercise and any prescribed care.
Cholesterol and lipid improvements
Pooled trials show black seed lowers total cholesterol by about 16 mg/dL, LDL by about 14 mg/dL, and triglycerides by about 21 mg/dL. HDL did not change overall and rose only with seed powder. These are modest reductions, best viewed as support alongside diet and any prescribed care.
Nasal and airway comfort
In a 15-day trial of 65 adults with seasonal nasal allergy symptoms, a branded oil extract standardized to 5% thymoquinone (250 mg with piperine, twice daily) lowered nasal and eye symptom scores more than placebo; the maker ran the study. In a 4-week trial in people with asthma, 1 g a day of oil added to usual care improved asthma control scores, but lung function did not change significantly.
Inflammation markers
Pooled analyses of controlled trials found lower blood CRP with Nigella sativa seed or oil, and two of three analyses also found lower TNF-alpha; one found no change in IL-6. These are blood markers, not felt benefits, and the trials used varied products, doses and populations.
Body weight and BMI
A pooled analysis of randomized trials found black seed reduced body weight by about 1.8 kg (10 trials) and BMI by about 0.85 versus placebo, with large differences between trials; waist size did not change significantly. The effect is small, so it fits only as one part of a broader eating and activity plan.
Thymoquinone content varies between products
An analysis of 11 commercial black seed oils and capsules found thymoquinone ranging from about 3 to 809 mg per 100 g, a more than 250-fold spread. The authors called for thymoquinone content to be regulated so buyers know what they are getting; a label that states the thymoquinone amount is one way to know the dose.
Traditional use vs modern evidence
Black seed has a long history in Middle Eastern, Persian and South Asian traditional medicine, including a honey-based preparation for upper-stomach complaints. Modern human trials cover a narrower set of uses, mostly with small, short studies, so its traditional reputation reaches well beyond what has been tested.
Oxidative stress markers: lower MDA, higher antioxidant capacity
Three pooled analyses of controlled trials (10, 12 and 20 trials) in adults taking Nigella sativa seed or seed oil found lower blood malondialdehyde, a lipid peroxidation marker, and higher total antioxidant capacity; in the 12-trial analysis the effects were SMD -0.56 and 0.48, with moderate heterogeneity. A smaller 5-trial analysis found only higher SOD. These are lab markers, not felt benefits, and products and doses varied.
Indigestion and upper-stomach comfort
In a placebo-controlled trial of 70 people with functional dyspepsia (ongoing upper-stomach discomfort), 5 mL a day of the oil in honey for 8 weeks, added to acid-reducing medicine, lowered indigestion severity scores more than placebo. A second trial, of 2 g a day of Nigella sativa added to H. pylori treatment in 51 people, found no difference in indigestion.
Mechanism of action
NF-κB signaling and leukotriene formation
A review of mostly cell and animal studies describes thymoquinone acting on the NF-κB pathway, which controls inflammatory responses. In human blood cells in the test tube, thymoquinone blocked 5-lipoxygenase and the formation of leukotrienes, signaling molecules involved in airway and inflammatory responses. How much of this happens at supplement doses in people is not established.
Nrf2 activation and antioxidant enzymes
In cell and animal studies summarized in the same review, black seed and thymoquinone raised antioxidant enzyme activity, scavenged free radicals and acted on the Nrf2 pathway that controls responses to oxidative stress. Pooled human trials found higher blood antioxidant capacity, SOD and glutathione peroxidase, which fits this mechanism but does not prove it.
Cell energy sensing through AMPK
The same review describes thymoquinone acting on AMPK, an enzyme that senses a cell's energy status and adjusts its metabolism, in laboratory work. Whether this has anything to do with the blood sugar changes seen in human trials is unknown.
Clinical trials
Meta-analysis of 7 trials of Nigella sativa on fasting blood sugar, HbA1c and blood lipids in type 2 diabetes (Daryabeygi-Khotbehsara et al. 2017, Complement Ther Med)
Adults with type 2 diabetes across 7 pooled clinical trials.
N. sativa lowered fasting blood sugar (about -17.8 mg/dL), HbA1c (about -0.7%), total cholesterol and LDL versus control. Triglycerides and HDL did not change significantly overall, though triglycerides fell in the oil subgroup. The authors note the analysis included only a few studies.
Randomized, double-blind, placebo-controlled trial of N. sativa oil 500 mg twice daily for 4 weeks as add-on therapy; 80 enrolled, 60 completed. Outcomes: Asthma Control Test, pulmonary function, blood eosinophils. (Koshak et al. 2017, Phytother Res)
People with asthma (80 enrolled).
N. sativa oil as add-on therapy improved the Asthma Control Test score (21.1 vs 19.6, p=0.044) and lowered blood eosinophils versus placebo. The change in FEV1 did not reach statistical significance (p=0.17). This is a single small 4-week trial, and the oil was taken on top of usual asthma treatment.
Meta-analysis of 17 randomized controlled trials examining black seed effects on total cholesterol, LDL, HDL and triglycerides (Sahebkar et al. 2016, Pharmacol Res)
17 pooled randomized controlled trials.
N. sativa reduced total cholesterol (about -15.7 mg/dL), LDL cholesterol (about -14.1 mg/dL), and triglycerides (about -20.6 mg/dL) across 17 randomized trials. HDL did not change significantly. These reductions are modest. Effects varied by preparation, with oil favored for cholesterol and LDL.
Double-blind, randomized, placebo-controlled trial of a traditional honey-based formulation giving 5 mL of N. sativa oil a day for 8 weeks, added to standard anti-secretory (acid-reducing) therapy (Mohtashami et al. 2015, J Ethnopharmacol)
70 people with functional dyspepsia by Rome III criteria, confirmed by upper endoscopy.
Hong Kong dyspepsia severity scores were significantly lower with the oil formulation than with placebo after 8 weeks (P<0.001), and fewer participants tested positive for H. pylori on a urease test. No serious adverse events were reported. Honey was part of the formulation and everyone also took acid-reducing medicine. A Cochrane review rated this single trial's result as high-certainty evidence.
Double-blind, placebo-controlled pilot trial of 2 g/day N. sativa or placebo for 8 weeks, each added to quadruple H. pylori therapy (Alizadeh-Naini et al. 2020, Phytother Res)
51 people with H. pylori infection and functional dyspepsia.
Dyspepsia scores did not differ significantly between the groups. H. pylori eradication was higher with N. sativa (p = .01), and quality of life, food intake, body weight and BMI rose more than with placebo. IL-8, hs-CRP and malondialdehyde did not differ between groups.
Randomized, double-blind, placebo-controlled trial of 250 mg Nigellin Amber (a supercritical-extracted N. sativa oil standardized to 5% thymoquinone) with 2.5 mg piperine, twice daily after food for 15 days. Most authors are employees of Sami-Sabinsa, which markets Nigellin Amber and supplied the product. (Majeed et al. 2024, Medicine (Baltimore))
65 adults aged 18 to 60 with two or more seasonal nasal allergy symptoms.
Total nasal and ocular symptom scores fell significantly more than with placebo, as did daily symptom episodes, and global impression of change was better. Serum IgE fell but not significantly versus placebo. No clinically significant changes in safety labs were seen. This was a single short, maker-run trial, and the capsule also contained piperine.
Double-blind, randomized, placebo-controlled trial of 300 mg Nigella sativa seed extract twice daily for 28 days at three outpatient clinics in Jakarta, analyzed by intention to treat. Reported adverse events were indigestion in 6 participants, nausea in 3 and constipation in 2; no electrolyte, liver or kidney problems were seen. (Rizka et al. 2017, Acta Med Indones)
76 older adults with high blood pressure in Indonesia (38 per group).
Systolic blood pressure fell from about 160 to 146 mmHg with the extract and from about 161 to 148 mmHg with placebo, a difference that was not significant (p=0.36); diastolic pressure did not differ either (p=0.35). The authors concluded the extract was not shown to lower blood pressure in this group.